$SODI
SOLITRON DEVICES INC Stock $sodi

$sodi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000165495423012842 Filed on October 12, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$4.136M	$2.579M
YoY Change	608.22%	17.92%
Cost Of Revenue	$3.059M	$1.682M
YoY Change	238.01%	13.19%
Gross Profit	$1.077M	$897.0K
YoY Change	-435.51%	27.96%
Gross Profit Margin	26.04%	34.78%
Selling, General & Admin	$859.0K	$614.0K
YoY Change	86.74%	23.05%
% of Gross Profit	79.76%	68.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$149.0K	$121.0K
YoY Change	56.84%	77.94%
% of Gross Profit	13.83%	13.49%
Operating Expenses	$859.0K	$614.0K
YoY Change	86.74%	23.05%
Operating Profit	$218.0K	$283.0K
YoY Change	-127.91%	40.1%
Interest Expense	$55.00K	$26.00K
YoY Change	103.7%	-3.7%
% of Operating Profit	25.23%	9.19%
Other Income/Expense, Net	$19.00K	-$83.00K
YoY Change	-93.43%	-173.45%
Pretax Income	$86.00K	$200.0K
YoY Change	-117.48%	-36.51%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%
Net Earnings	$86.00K	$200.0K
YoY Change	-117.48%	-36.51%
Net Earnings / Revenue	2.08%	7.75%
Basic Earnings Per Share	$0.04
Diluted Earnings Per Share	$0.04	$0.10
COMMON SHARES
Basic Shares Outstanding	2.083M shares	2.083M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.579M	$1.849M
YoY Change	28.69%	-1.91%
Cash & Equivalents	$1.909M	$1.098M
Short-Term Investments	$670.0K	$751.0K
Other Short-Term Assets	$256.0K	$3.285M
YoY Change	0.79%	628.38%
Inventory	$4.384M	$2.076M
Prepaid Expenses
Receivables	$2.728M	$952.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$9.947M	$8.162M
YoY Change	32.82%	-2.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.297M	$7.218M
YoY Change	-2.03%	46.47%
Goodwill
YoY Change
Intangibles	$232.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$271.0K	$14.00K
YoY Change	1706.67%	0.0%
Total Long-Term Assets	$9.530M	$7.232M
YoY Change	27.7%	2.92%
TOTAL ASSETS
Total Short-Term Assets	$9.947M	$8.162M
Total Long-Term Assets	$9.530M	$7.232M
Total Assets	$19.48M	$15.39M
YoY Change	30.26%	-0.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$818.0K	$373.0K
YoY Change	174.5%	96.32%
Accrued Expenses	$1.125M	$946.0K
YoY Change	41.69%	12.35%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.857M	$109.0K
YoY Change	1558.04%	-3.54%
Total Short-Term Liabilities	$4.530M	$1.505M
YoY Change	264.73%	24.48%
LONG-TERM LIABILITIES
Long-Term Debt	$2.565M	$2.593M
YoY Change	-4.11%	-4.03%
Other Long-Term Liabilities	$750.0K
YoY Change
Total Long-Term Liabilities	$3.315M	$2.593M
YoY Change	23.93%	-4.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.530M	$1.505M
Total Long-Term Liabilities	$3.315M	$2.593M
Total Liabilities	$8.095M	$4.098M
YoY Change	106.66%	4.78%
SHAREHOLDERS EQUITY
Retained Earnings	$10.94M	$10.85M
YoY Change	3.28%	-2.08%
Common Stock	$21.00K	$21.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.412M	$1.412M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$11.38M	$11.30M
YoY Change
Total Liabilities & Shareholders Equity	$19.48M	$15.39M
YoY Change	30.26%	-0.29%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$86.00K	$200.0K
YoY Change	-117.48%	-36.51%
Depreciation, Depletion And Amortization	$149.0K	$121.0K
YoY Change	56.84%	77.94%
Cash From Operating Activities	$393.0K	$974.0K
YoY Change	-5.76%	-324.42%
INVESTING ACTIVITIES
Capital Expenditures	$60.00K	$90.00K
YoY Change	-88.68%	-122.73%
Acquisitions
YoY Change
Other Investing Activities	-$2.492M	$1.645M
YoY Change	4884.0%	-162.71%
Cash From Investing Activities	-$2.552M	$1.555M
YoY Change	340.0%	-151.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.00K	-26.00K
YoY Change	15.38%	4.0%
NET CHANGE
Cash From Operating Activities	393.0K	974.0K
Cash From Investing Activities	-2.552M	1.555M
Cash From Financing Activities	-30.00K	-26.00K
Net Change In Cash	-2.189M	2.503M
YoY Change	1058.2%	-171.97%
FREE CASH FLOW
Cash From Operating Activities	$393.0K	$974.0K
Capital Expenditures	$60.00K	$90.00K
Free Cash Flow	$333.0K	$884.0K
YoY Change	-394.69%	-2426.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	952000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	285000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8162000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7218000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q3	sodi	Marketable Securities Current1 MarketableSecuritiesCurrent1	751000	usd
CY2023Q1	sodi	Marketable Securities Current1 MarketableSecuritiesCurrent1	1895000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	2076000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14000	usd
CY2023Q3	us-gaap	Assets Assets	15394000	usd
CY2023Q1	us-gaap	Assets Assets	15104000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	373000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	141000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2593000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2648000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	4098000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3837000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2083436	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1834000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1834000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	701000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	202000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	27000	usd
CY2022Q3	sodi	Realized Gain On Investments RealizedGainOnInvestments	24000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	106000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	113000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	315000	usd
CY2022Q3	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2083436000	shares
	us-gaap	Net Income Loss NetIncomeLoss	29000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1086000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	244000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	138000	usd
	sodi	Net Realized And Unrealized Losses On Investments NetRealizedAndUnrealizedLossesOnInvestments	305000	usd
	sodi	Net Realized And Unrealized Losses On Investments NetRealizedAndUnrealizedLossesOnInvestments	-87000	usd
	us-gaap	Interest Income Short Term Investment Other InterestIncomeShortTermInvestmentOther	16000	usd
	us-gaap	Interest Income Short Term Investment Other InterestIncomeShortTermInvestmentOther	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	168000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-255000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-339000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-16000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	82000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	255000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-10000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	232000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	55000	usd
	sodi	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	46000	usd
	sodi	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	40000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	967000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1188000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4419000	usd
	sodi	Principal Payments On Mortgage Loan PrincipalPaymentsOnMortgageLoan	-53000	usd
	sodi	Principal Payments On Mortgage Loan PrincipalPaymentsOnMortgageLoan	-51000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-53000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-51000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2651000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3282000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1447000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4088000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4098000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	806000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	53000	usd
	us-gaap	Interest Paid Net InterestPaidNet	55000	usd
	sodi	Deferred Tax Liability Related To Unrecognized Gains And Losses DeferredTaxLiabilityRelatedToUnrecognizedGainsAndLosses	56000	usd
CY2023	sodi	Deferred Tax Liability Related To Unrecognized Gains And Losses DeferredTaxLiabilityRelatedToUnrecognizedGainsAndLosses	229000	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	0	usd
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3350000	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	129000	usd
CY2022Q1	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Ending Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsEndingBalance	471000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	6882000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4806000	usd
CY2023Q3	us-gaap	Inventory Adjustments InventoryAdjustments	2076000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	7141000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4726000	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	2415000	usd
CY2023Q3	sodi	Other Inventory Net Of Reserve OtherInventoryNetOfReserve	400000	usd
CY2023Q1	sodi	Other Inventory Net Of Reserve OtherInventoryNetOfReserve	589000	usd
	sodi	Inventory Consisted InventoryConsisted	100% of the wafer bank inventory consisted of wafers manufactured between calendar year 2018 and 2022
CY2023Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	369000	usd
CY2023Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	363000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3000	usd
CY2023Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	52000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	20000	usd
CY2023Q3	sodi	Return Allowance ReturnAllowance	471000	usd
CY2023Q1	sodi	Return Allowance ReturnAllowance	471000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	50000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	50000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	946000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	907000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000091668
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity File Number EntityFileNumber	001-04978
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2083436	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	487827	shares
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-08-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	SOLITRON DEVICES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-1684144
	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Sansburys Way
	us-gaap	Interest And Other Income InterestAndOtherIncome	20000	usd
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33411
	dei	City Area Code CityAreaCode	561
	dei	Local Phone Number LocalPhoneNumber	848‑4311
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2083436	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1098000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3000000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q3	sodi	Customer Deposit Current CustomerDepositCurrent	77000	usd
CY2023Q1	sodi	Customer Deposit Current CustomerDepositCurrent	31000	usd
CY2023Q3	sodi	Mortgage Loan Current Portion MortgageLoanCurrentPortion	109000	usd
CY2023Q1	sodi	Mortgage Loan Current Portion MortgageLoanCurrentPortion	107000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	946000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	910000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1505000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1189000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	487827	shares
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10853000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10824000	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1412000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1412000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	11296000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11267000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15394000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15104000	usd
CY2022Q3	us-gaap	Revenues Revenues	2187000	usd
	us-gaap	Revenues Revenues	4617000	usd
	us-gaap	Revenues Revenues	4323000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1682000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1486000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3113000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2805000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	897000	usd
	us-gaap	Gross Profit GrossProfit	1504000	usd
	us-gaap	Gross Profit GrossProfit	1518000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	614000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	499000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1156000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1075000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	283000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	348000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	443000	usd
CY2022Q3	sodi	Scrap Income ScrapIncome	6000	usd
CY2022Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2000	usd
CY2022Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	2000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	26000	usd
	us-gaap	Interest Expense InterestExpense	53000	usd
	us-gaap	Interest Expense InterestExpense	55000	usd
CY2023Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	18000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	2000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	19000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	5000	usd
CY2023Q3	sodi	Realized Gain On Investments RealizedGainOnInvestments	210000	usd
	sodi	Realized Gain On Investments RealizedGainOnInvestments	332000	usd
	sodi	Realized Gain On Investments RealizedGainOnInvestments	32000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-291000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-637000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	55000	usd
CY2023Q3	sodi	Scrap Income ScrapIncome	0	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	6000	usd
	sodi	Scrap Income ScrapIncome	0	usd
	sodi	Scrap Income ScrapIncome	604000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-83000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-319000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	643000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	200000	usd
	us-gaap	Net Income Loss NetIncomeLoss	29000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1086000	usd
CY2023Q3	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	0.10
CY2022Q3	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	0.15
	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	0.01
	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	0.52
CY2023Q3	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2083436000	shares
	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2083436000	shares
	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2083436000	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	315000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	11527000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11267000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-171000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	11096000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	200000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	11296000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	41000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-50000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	882000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	803000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	43000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1111000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2495000	usd
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	1000000	usd
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	0	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	1476000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	140000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1737000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. The Company could have reasonably used different accounting estimates. This applies in particular to inventory and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The Company believes COVID-19 had a negative impact on the Company’s bookings and net sales in fiscal 2023. The Company believes COVID-19 had a negative impact to net sales in the first quarter of fiscal 2024 due to bookings being negatively affected in fiscal 2023. </p>
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	3000000.0	usd
CY2023Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	0	usd
CY2023Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	986000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	485000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	266000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	751000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	992000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	930000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	27000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1895000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and account receivables. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on the accounts. As of August 31, 2023, all non-interest bearing checking accounts were FDIC insured to a limit of $250,000. Deposits in excess of FDIC insured limits were approximately $3,350,000 at August 31, 2023, as compared to $129,000 at February 28, 2023. With respect to the account receivables, most of the Company’s products are custom made pursuant to contracts with customers whose end-products are sold to the United States Government. The Company performs ongoing credit evaluations of its customers’ financial condition and maintains allowances for potential credit losses. Actual losses and allowances have historically been within management’s expectations. </p>
CY2023Q3	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Beginning Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsBeginningBalance	471000	usd
CY2022Q1	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Beginning Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsBeginningBalance	471000	usd
CY2023Q3	sodi	Accrued Allowances AccruedAllowances	0	usd
CY2022Q1	sodi	Accrued Allowances AccruedAllowances	0	usd
CY2023Q3	sodi	Credits Issued CreditsIssued	0	usd
CY2022Q1	sodi	Credits Issued CreditsIssued	0	usd
CY2023Q3	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Ending Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsEndingBalance	471000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2579000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2187000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4617000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4323000	usd
CY2023Q3	sodi	Concentration Risk Percentage One ConcentrationRiskPercentageOne	0.71	pure
CY2022Q3	sodi	Concentration Risk Percentage One ConcentrationRiskPercentageOne	0.66	pure
	sodi	Concentration Risk Percentage One ConcentrationRiskPercentageOne	0.65	pure
	sodi	Concentration Risk Percentage One ConcentrationRiskPercentageOne	0.52	pure
CY2023Q3	us-gaap	Assets Net AssetsNet	0	usd
CY2022Q1	us-gaap	Assets Net AssetsNet	3000	usd

Files In Submission

Name	View Source	Status
0001654954-23-012842-index-headers.html	Edgar Link	pending
0001654954-23-012842-index.html	Edgar Link	pending
0001654954-23-012842.txt	Edgar Link	pending
0001654954-23-012842-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sodi-20230831.xsd	Edgar Link	pending
sodi_10q.htm	Edgar Link	pending
sodi_ex311.htm	Edgar Link	pending
sodi_ex321.htm	Edgar Link	pending
sodi-20230831_def.xml	Edgar Link	unprocessable
sodi-20230831_lab.xml	Edgar Link	unprocessable
sodi-20230831_cal.xml	Edgar Link	unprocessable
sodi-20230831_pre.xml	Edgar Link	unprocessable
sodi_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SODI
SOLITRON DEVICES INC Stock $sodi

2023 Q4 Form 10-Q Financial Statement

#000165495423012842 Filed on October 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SODI SOLITRON DEVICES INC Stock $sodi

2023 Q4 Form 10-Q Financial Statement

#000165495423012842 Filed on October 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SODI
SOLITRON DEVICES INC Stock $sodi